首页> 外文期刊>Trials >The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation
【24h】

The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation

机译:基于正念的认知疗法在改善炎症性肠病患者生活质量中的应用:一项具有嵌入式过程评估的试验性随机对照试验的研究方案

获取原文
           

摘要

Background Inflammatory bowel disease (IBD) is a chronic condition with an unpredictable disease course. Rates of anxiety and depression among IBD patients in relapse (active disease symptoms) as well as in remission are higher than in the general population. Previous studies suggest that the prolonged effect of pain, anxiety, distress and depression have a detrimental effect on patients’quality of life (QoL). Poor QoL in itself is associated with further symptom relapse. Mindfulness based cognitive therapy (MBCT) is a psychological group intervention that has the potential to improve QoL. When used in other chronic conditions, it demonstrated reduced negative effect from pain and psychological factors at completion of an 8-week MBCT course. The effect of MBCT has never been researched in IBD. The aim of this study is to obtain the information required to design a full scale randomised controlled trial (RCT) that will examine the effectiveness of MBCT in improving quality of life for IBD patients. Methods/Design This is an exploratory RCT with embedded process evaluation. Forty IBD patients will be recruited from NHS outpatient gastroenterology clinics and will be randomised to either a MBCT (intervention) group or to a wait-list (control) group. All participants will undergo 16?h of structured group training over an 8-week period, with the control group starting 6?months later than the intervention group. Primary outcomes are recruitment, completion/retention rates and adherence and adaptation to the MBCT manual for IBD patients. The secondary outcome is to assess the feasibility of collecting reliable and valid data on proposed outcome measures such as quality of life, anxiety, depression, disease activity and mindful awareness. The process evaluation will use a survey and focus groups to assess the acceptability of the intervention and trial procedures for IBD patients. Discussion The outcomes of this study will help define the barriers, uptake and perceived benefits of MBCT program for IBD patients. This information will enable the design of a full-scale study assessing the effect of MBCT on quality of life for IBD patients. Trial registration Current Controlled Trials: ISRCTN27934462
机译:背景炎症性肠病(IBD)是一种慢性疾病,病程不可预测。 IBD患者在复发(活动性疾病症状)和缓解方面的焦虑和抑郁发生率高于一般人群。先前的研究表明,疼痛,焦虑,困扰和沮丧的长期影响会对患者的生活质量(QoL)产生不利影响。 QoL差本身与进一步的症状复发有关。基于正念的认知疗法(MBCT)是一种心理团体干预措施,有可能改善QoL。当在其他慢性病中使用时,在完成为期8周的MBCT疗程后,它显示出减轻了由疼痛和心理因素引起的负面影响。在IBD中从未研究过MBCT的作用。这项研究的目的是获得设计全面随机对照试验(RCT)所需的信息,该试验将研究MBCT在改善IBD患者生活质量方面的有效性。方法/设计这是具有嵌入式过程评估的探索性RCT。将从NHS门诊胃肠病诊所招募40名IBD患者,并将其随机分为MBCT(干预)组或候补(对照组)组。所有参与者将在8周的时间内接受16小时的结构化小组培训,而对照组比干预组晚6个月开始。主要结果是招募,完成/保留率以及对IBD患者的MBCT手册的依从性和适应性。次要结果是评估就拟议结果测量(例如生活质量,焦虑,抑郁,疾病活动和正念意识)收集可靠和有效数据的可行性。过程评估将使用调查和焦点小组来评估IBD患者的干预和试验程序的可接受性。讨论本研究的结果将有助于确定MBCT计划对IBD患者的障碍,摄取和可感知的益处。这些信息将有助于设计一项全面的研究,评估MBCT对IBD患者的生活质量的影响。试用注册当前控制的试用:ISRCTN27934462

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号